Edesa Biotech Inc (EDSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,564 | 1,037 | 2,041 | 2,800 | 4,268 |
| Receivables | 351 | 271 | 551 | 1,112 | 744 |
| TOTAL | $2,072 | $1,676 | $3,047 | $4,242 | $5,416 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 7 | 8 |
| Intangibles | 2,054 | 2,079 | 2,104 | 2,129 | 2,155 |
| Other Non-Current Assets | 39 | 60 | 77 | 96 | 253 |
| TOTAL | $2,092 | $2,138 | $2,181 | $2,233 | $2,416 |
| Total Assets | $4,164 | $3,814 | $5,228 | $6,475 | $7,832 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,900 | 1,813 | 2,322 | 2,093 | 1,909 |
| TOTAL | $1,900 | $1,833 | $2,361 | $2,151 | $1,987 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,900 | $1,833 | $2,361 | $2,151 | $1,987 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,936 | 3,468 | 3,247 | 3,216 | 3,172 |
| Common Shares | 47,562 | 47,236 | 47,236 | 47,136 | 46,934 |
| Retained earnings | -60,232 | -58,589 | -57,627 | -55,959 | -54,097 |
| Other shareholders' equity | -224 | -243 | -225 | -226 | -215 |
| TOTAL | $2,264 | $1,981 | $2,867 | $4,324 | $5,845 |
| Total Liabilities And Equity | $4,164 | $3,814 | $5,228 | $6,475 | $7,832 |